FDA finalizes safety reporting guidances for sponsors and investigators
Regulatory NewsJoanne S. Eglovitch
Clinical TrialsGuidanceMedical DevicesPharmaceuticalsPharmacovigilance/postmarket surveillancePostmarketing clinical follow up (PMCF)Postmarketing requirement/postmarketing commitmentRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)